Background:
The p21-activated kinases 4 (PAK4) refer to a promising target for cancer treatment. Currently, a wide range of PAK4 inhibitors has been reported.
Objective:
To study the structural requirements of quinoline derivatives as PAK4 inhibitors and design novel PAK4 inhibitors.
Method:
In the present study, a set of quinazoline PAK4 inhibitors underwent CoMFA, CoMSIA, molecular docking, as well as molecular dynamics simulations.
Results:
The built CoMFA (q2=0.792, r2=0.994, r2pred =0.74) and CoMSIA (q2=0.873, r2=0.994, r2pred=0.81) models exhibited high robustness and prominent predicting ability. As revealed from the results of molecular docking and molecular dynamics simulations, hydrogen bond and hydrophobic interactions primarily impact the affinity of PAK4 inhibitors, and Leu398 acts as an amino acid that leads to significant stabilization of the mentioned inhibitors. Moreover, the present study developed five novel molecules exhibiting high biological activity predicted and satisfactory ADME properties.
Conclusion:
The structural basis of PAK4 with respect to the activities of its inhibitors was revealed, which may be conducive to designing novel PAK4 inhibitors.
Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists